Delivery Order SPE2DB22D3301-SPE2DB25FX3NG

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,009.96, is a delivery order for the supply of FLUCYTOSINE 250 MG CAPSULE UD 30S. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order valued at $13,732.92 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract delivers the pharmaceutical product FLUCYTOSINE 500 MG CAPSULE UD 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,772.40, is for the delivery of the drug flucytosine 500 mg capsules, a prescription medication used to treat fungal infections. The contract is a firm fixed-price delivery order with a completion date of February 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,392,825 units of the pharmaceutical product Flucytosine 250 mg Capsules. The contract has a firm fixed price of $17,628.71 and a completion date of August 9, 2024. The contract is not set aside for a specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUCYTOSINE 500 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $3,621.80. The contract type is Firm Fixed Price and the pricing type is Firm Fixed Price. The ultimate completion date for this delivery order is June 26, 2025. This contract award is not designated as a...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB25FM9J5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567466690 - FLUCYTOSINE 500 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $46,634.40 and a period of performance through March 6, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product: FLUCYTOSINE 250 MG CAPSULE UD 30S. The delivery order has a potential value of $12,937.31 and a completion date of December 20, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 150 mg Fluconazole tablets. The award has a ceiling value of $1,364.46 and an ultimate completion date of June 10, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,630.71 firm fixed-price contract is for the supply of FLUORESCITE 10% VIAL 5ML, a medical product. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,998.87 firm-fixed-price contract is for the supply of FLUORESCITE 10% VIAL 5ML, a medical product. The order is placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which covers a broad range of pharmaceutical and medical supplies to support military healthcare programs...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX3NG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Flucytosine 500 mg capsules. The $14,816.38 firm fixed price delivery order has an ultimate completion date of October 11, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 1/9/25, 9:02 AM